학술논문

A Pictorial Exploration of Mammary Paget Disease: Insights and Perspectives.
Document Type
Article
Source
Cancers. Nov2023, Vol. 15 Issue 21, p5276. 13p.
Subject
*BREAST tumor treatment
*BREAST cancer prognosis
*BREAST tumor diagnosis
*ADENOCARCINOMA
*IMMUNOHISTOCHEMISTRY
*MAGNETIC resonance imaging
*EARLY detection of cancer
*MAMMOGRAMS
*DUCTAL carcinoma
*BREAST cancer
*ADJUVANT treatment of cancer
*CHEMORADIOTHERAPY
*QUALITY of life
*BREAST
*BREAST tumors
*CARCINOMA in situ
*SYMPTOMS
BODY fluid examination
Language
ISSN
2072-6694
Abstract
Simple Summary: This review provides a comprehensive overview of mammary Paget disease (MPD) from its historical origins to the current diagnostic and treatment strategies while also exploring promising avenues for future advancements in the field. With improved understanding and ongoing research efforts, we aim to enhance the prognosis and quality of life for individuals affected by this relatively uncommon condition. Mammary Paget disease (MPD) is a rare condition primarily affecting adult women, characterized by unilateral skin changes in the nipple–areolar complex (NAC) and frequently associated with underlying breast carcinoma. Histologically, MPD is identified by large intraepidermal epithelial cells (Paget cells) with distinct characteristics. Immunohistochemical profiles aid in distinguishing MPD from other skin conditions. Clinical evaluation and imaging techniques, including magnetic resonance imaging (MRI), are recommended if MPD is suspected, although definitive diagnosis always requires histological examination. This review delves into the historical context, epidemiology, pathogenesis, clinical manifestations, and diagnosis of MPD, emphasizing the need for early detection. The classification of MPD based on pathogenesis is explored, shedding light on its varied presentations. Treatment options, including mastectomy and breast-conserving surgery, are discussed with clear guidelines for different scenarios. Adjuvant therapies are considered, particularly in cases with underlying breast cancer. Prognostic factors are outlined, underlining the importance of early intervention. Looking to the future, emerging techniques, like liquid biopsy, new immunohistochemical and molecular markers, and artificial intelligence-based image analysis, hold the potential to transform MPD diagnosis and treatment. These innovations offer hope for early detection and improved patient care, though validation through large-scale clinical trials is needed. [ABSTRACT FROM AUTHOR]